Literature DB >> 6337098

Effects of carrier ampholyte contamination on the biological and biochemical properties of streptococcal pyrogenic exotoxin type C.

T G Bloomster, D W Watson.   

Abstract

Three streptococcal pyrogenic exotoxins (SPEs), designated as SPE A, B, and C, have been purified and characterized. Routine purification of the SPEs includes the technique of isoelectric focusing. An earlier study showed that the removal of commercial carrier ampholytes (Ampholines) from SPE was difficult. The physiochemical properties of SPE C were previously reported; however, the SPE C preparation used in those experiments was contaminated with Ampholines. As an alternative to Ampholines, we used simple buffers to generate the isoelectric focusing pH gradient and used this SPE C in a comparative study to evaluate the effects of Ampholine contamination on the biological and biochemical properties of this toxin. We found that Ampholine contamination overestimates protein concentration; consequently, the biological activity of SPE C was actually greater than reported. The most serious effect of Ampholines in SPE C was on amino acid analysis. The presence of Ampholines causes an apparent increase in neutral amino acids and a decrease in basic amino acids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337098      PMCID: PMC347942          DOI: 10.1128/iai.39.1.311-314.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Purification and characterization of group A streptococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert; K M Bettin; D W Watson
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

3.  Enhanced immune response after immunosuppression by Streptococcal pyrogenic exotoxin.

Authors:  E E Hanna; D W Watson
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

4.  Deregulation of mouse antibody-forming cells by streptococcal pyrogenic exotoxin. II. Modification of spleen T-cell-complemented nude mouse PFC responses.

Authors:  M L Hale; E E Hanna
Journal:  Cell Immunol       Date:  1976-10       Impact factor: 4.868

5.  Detection of microgram quantities of carrier ampholytes in electrofocused proteins by thin-layer chromatography.

Authors:  T G Bloomster; D W Watson
Journal:  Anal Biochem       Date:  1981-05-01       Impact factor: 3.365

6.  Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin.

Authors:  C M Cunningham; E L Barsumian; D W Watson
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

7.  Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock.

Authors:  P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

8.  Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins.

Authors:  E L Barsumian; P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

9.  A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock.

Authors:  Y B Kim; D W Watson
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

10.  Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins.

Authors:  D W WATSON
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

View more
  1 in total

1.  Purification and partial biochemical characterization of normal human interleukin 1.

Authors:  J A Schmidt
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.